Only sidechain-dependent GRD2 polar contacts to Ex-mode (blue letters) or to RasGAP-mode (green letters) Cdc42 molecules are shown. Underlined residues participate in salt bridge interactions. Italicized residues are used by just one of the two GRD2 molecules. Secondary structure pertaining to Ex domains is colored blue. Structure pertaining to the 31 residues without a structural equivalent in RasGAPs is magenta. Disordered residues at the C-terminus are shown as dashed lines.
Supplementary Figure S4, related to Figures 4 and 5.
Annotated sequence alignment for human GTPases. Only residues equivalent to 1 -177 in Cdc42 are included in the alignment. Sidechain-dependent polar contacts from RasGAPmode (green letters) or Ex-mode (blue letters) Cdc42 molecules to the GRD2 are indicated. Residues used in both binding modes are in red. Underlined residues are participating in salt bridges. Italicized residues are used by just one of the two molecules in that binding mode. Arginine 66 (asterisk) is involved in salt-bridge interactions in the RasGAP-mode and hydrogen bonds in the Ex-mode. All four Cdc42 molecules have very similar secondary structures. The secondary structure of molecule C of the RasGAP mode is shown above the sequence alignment. Figure S5 , related to Figure 6 . Isothermal titration calorimetry using wild-type and mutant GRDs. All experiments have Cdc42 (Q61L; residues 1-177) in the syringe and the GRD protein in the cell. A, Wild-type GRD1 at 20°C. B, Wild-type GRD2 at 20°C. We speculate that the Ex domain must partially unfold to create the Ex-mode binding sites we see at 30°C. C, 30°C titration using GRD1 with alanine substitutions at six important Ex-mode contacting positions. D, 30°C titration using GRD2 with alanine substitutions at the same six important Ex-mode contacting positions as in C.
Supplementary
Supplementary Figure S6 , related to Figure 6 . In vitro binding studies. 2μg His-Cdc42-Q61L in 1 ml Buffer A (50mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100 and 1mM EGTA), containing protease and phosphatase inhibitors was pre-cleared with 40μl glutathione-Sepharose at 4 °C for 1 h. Next, 3μg GST-IQGAP1-C, GST-IQGAP1-C-6A or GST on glutathione-Sepharose beads was added and samples were rotated for 3 h at 4 °C. After five washes with Buffer A, samples were resolved by SDS-PAGE. The half of the gel containing GST-IQGAP1-C (WT) and GST-IQGAP1-C-6A (6 alanine mutations in Ex mode residues; see Methods) was stained with Coomassie Blue, while the portion containing Cdc42 was transferred to PVDF and probed with anti-Cdc42 antibodies and imaged. WB = Western blot.
